Is This "Biotech Winter" Worse Than Others? Stocks To Watch

Is the current “biotech winter” is worse than others? Dr. Lindsay Rosenwald discusses the latest “biotech winter.” He talks about signs of improvement in biotech, highlighting iShares Trust iShares Biotechnology ETF (IBB). IBB is down over 2% year-to-date. He goes over types of biotech companies to watch such as Fortress Biotech (FBIO). He also outlines the M&A outlook for biotech. Tune in to find out more about the stock market today.
#biotechnology #stocks #healthcare #investing #trading #stockmarket #wallstreet #money #finance #businessnews #news

[@Dhruva_Nakshatra]

"built for a storm" ... what? this stock is 33 cents ... down from $6... looks like the storm came and blew the house down

[@mysterio5837]

AQST. 6 FDA approvals, lead PharmFilm Tech, 109 Anaphlaxyis film going to Stage 3 , Libervant Gloabl and less than 95Mil

[@ayenewwolde4393]

cccc